(0) items

Protein Kinase Ck2,9780470963036
This item qualifies for

Your order must be $59 or more, you must select US Postal Service Shipping as your shipping preference, and the "Group my items into as few shipments as possible" option when you place your order.

Bulk sales, PO's, Marketplace Items, eBooks, Apparel, and DVDs not included.

Protein Kinase Ck2



Pub. Date:

Questions About This Book?

Why should I rent this book?
Renting is easy, fast, and cheap! Renting from can save you hundreds of dollars compared to the cost of new or used books each semester. At the end of the semester, simply ship the book back to us with a free UPS shipping label! No need to worry about selling it back.
How do rental returns work?
Returning books is as easy as possible. As your rental due date approaches, we will email you several courtesy reminders. When you are ready to return, you can print a free UPS shipping label from our website at any time. Then, just return the book to your UPS driver or any staffed UPS location. You can even use the same box we shipped it in!
What version or edition is this?
This is the 1st edition with a publication date of 1/14/2013.
What is included with this book?
  • The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any CDs, lab manuals, study guides, etc.
  • The Rental copy of this book is not guaranteed to include any supplemental materials. You may receive a brand new copy, but typically, only the book itself.


The importance of CK2 in cancer and other diseases has generated a significant amount of literature on the protein, and an international community of CK2 researchers. The International Union of Biochemistry and Molecular Biology (IUMBMB) sponsors periodic international conferences on CK2, making the protein a natural topic for a Wiley-IUBMB publication. Protein Kinase CK2 will deal with structural aspects underlying the constitutive activity of CK2, its specific susceptibility to pharmacological inhibition and its extraordinary pleiotropy. In the second part the fundamental role of CK2 in a wide number of biological functions will be illustrated, while the third part will be devoted to the unusual mode of implication of CK2 in neoplastic transformation, with an appendix reviewing its potential relevance to other pathologies.

Table of Contents

1. “CK2, a protein kinase for all seasons” (Lorenzo A. Pinna Dept. Biological Chemistry, University of Padua, Padua, Italy.

2. “CK2 structures in the light of the spine concept of eukaryotic protein kinases “ (Karsten Niefind, University of Cologne, Institute of Biochemistry, Cologne, Germany. E

3. “Structural bases for CK2 inhibition” (Roberto Battistutta, Department of Chemistry, University of Padua- Padova, Italy.

4. “The interactome of protein kinase CK2” (Mathias Montenarth, University of the Saarland, Medical Biochemistry and Molecular Biology, Homburg, Germany.

5. “The phosphoproteome generated by protein kinase CK2” (Mauro Salvi & Lorenzo A. Pinna Dept. Biological Chemistry, University of Padua, Padua, Italy.

6. “Intersection of CK2 with other signalling pathways” (David Litchfield, University of Western Ontario, Department of Biochemistry, London, Ontario, Canada.

7. “The role of protein kinase CK2 in the p53 response” (David W. Meek, University of Dundee, Biomedical Research Institute Ninewells Hospital, Dundee, UK.

8. “CK2 in embryonic development” (Isabel Dominguez, Boston University School of Medicine, Boston, MA, USA.

9. “Role of CK2 in the control of epithelial cell plasticity” (Claude Cochet, INSERM U873 iRTSV- CEA Grenoble, France.

10. “CK2 and circadian rhythm” 

11. “The pivotal role of CK2 in chaperoning the kinome” (Yoshihiko Miyata, Kyoto University, Dept. Cell & Develop. Biology, Kyoto, Japan.

12. “CK2: a global regulator of cell survival” (Olaf-G. Issinger, University of Southern Denmark, Institute of Biochemistry and Molecular Biology, Odense, Denmark.

13. “Specific features of plant CK2” (Montserrat Pages, CSIC, CRAG, Barcelona, Spain.


14. “The oncogenic potential of CK2” (David C. Seldin, Boston University Medical Center, Department of Medicine, Boston MA, USA.

15. “CK2 suppression of apoptosis and its implication in cancer biology and therapy” (Khalil Ahmed, University of Minnesota and V.A. Medical Center, Minneapolis, MN, USA.

16. “Abnormal levels of CK2 and the generation of cancer “addiction” (Maria Ruzzene, Dept. Biological Chemistry, University of Padua, Padua, Italy.

17. “CK2 as an ideal target in cancer therapy: combining inhibitors of CK2 with various classes of chemotherapeutic agents” (Kenna Anderes, Cylene Pharmaceuticals, Cancer Biology, San Diego, CA, USA.

18. “ CK2 in normal and malignant hematopoiesis” (Francesco Piazza, Venetian Institute of Molecular Medicine – VIMM, Padova, Italy.

Please wait while the item is added to your cart...